Category: Maximizing Quality of Life
Nocturia, or frequent nighttime urination, is a familiar condition for many older Americans, impacting about 40 million adults in the U.S.[i],[ii] Research shows that 68 percent of adults over the age of 50 typically wake up 1.5 to 2 times during the night due to nocturia.[iii] Too often, though, nocturia is accepted as a normal part of aging and simply a fact of life for those suffering from the condition. Older adults often don’t report issues because of these assumptions, and healthcare professionals too often fail to ask about frequency of nighttime urination.
Dr. Steven A. Kaplan, Professor of Urology at the Icahn School of Medicine at Mount Sinai and Director of the Benign Urologic Diseases and The Men’s Health Program at Mount Sinai Health System has dedicated his career to empowering older Americans to optimize their health as they age. He shares the difficulties in diagnosing this debilitating condition, which is commonly associated with serious quality of life issues, including increased falls and fractures, decreased productivity during the day, depression, hypertension, and neurologic disease.
It is estimated that nocturia-related falls create an annual cost of $1.5 billion, and nocturia-related sick leave and lost productivity costs $61 billion annually in the U.S.[iv],[v] Studies have even shown an association between nocturia and increased mortality rates.[v] From his research, Dr. Kaplan shares the factors that contribute to nocturia, including nocturnal polyuria and other underlying medical conditions, including diabetes and depression.
Steven Kaplan– Professor of Urology, Icahn School of Medicine at Mount Sinai and Director, Benign Urologic Diseases and The Men's Health Program, Mount Sinai Health System, New York, New York
Professor of Urology, Icahn School of Medicine at Mount Sinai and Director, Benign Urologic Diseases and The Men's Health Program
Mount Sinai Health System
New York, New York
Dr. Steven Kaplan is an internationally renowned authority and one of the primary thought leaders in the study of benign diseases of the prostate, the association of metabolic factors and voiding dysfunction and female urology. He has written for over 900 publications including 275 peer reviewed and 570 peer-reviewed invited articles, and 90 book chapters and non–peered reviewed articles. His landmark study, published in JAMA in 2006, changed the way medications are used in the treatment of men with symptoms related to both benign prostate enlargement and bladder dysfunction. He has made over 340 presentations in more than 35 countries. He is the co-author of five books and is on the editorial board of numerous journals including Urology, Journal of Urology, and Urology Times.
Dr. Kaplan is a member of more than 30 professional organizations, and is a Diplomat of the American Board of Urology and a Fellow of the American College of Surgeons. He has been awarded five NIH grants and has received over $13 million in research funding. He serves as both member and / or chair of numerous study sections for the NIH, and more recently, he chaired the NIDDK Prostate Strategic Planning Committee and currently chairs the AUA Research Committee on Advocacy. He also has served on the American Urologic Association Guidelines Panel for BPH. He was awarded the John K. Lattimer Award for Lifetime Achievement in Urology by the National Kidney Foundation. Dr. Kaplan joined Mount Sinai from Weill Cornell Medical College, where he held the tenured position of E. Darracott Vaughan, Jr. Professor of Urology as well as Director of the Iris Cantor Men’s Health Center. In that position, he was responsible for the development of a new discipline within Urology, Integrated Men’s Health. Over is tenure at Weill Cornell Medical College, he was actively engaged with teaching and supervising both residents and fellows and was the Director of the Fellowship Program in Male and Female Voiding Dysfunction. Prior to this, he held the tenured position of Given Foundation Professor of Urology at Columbia University and was the Vice Chairman and Program Director. Dr. Kaplan graduated from Mount Sinai School of Medicine in 1982 and was elected to the AOA Honor Society. Dr. Kaplan’s postgraduate training included an internship and residency in the Department of Surgery at Mount Sinai Hospital as well as a residency in Urology at the Squier Urologic Clinic, Columbia University. He was an American Urologic Association Scholar between 1988 – 1990 that focused on identifying molecular markers and urodynamic parameters that herald bladder and prostate dysfunction.